2m 2m 2m 2m 2m 2m 2m
Neurocrine Biosc (NBIX)
NASDAQ
$142.98-$0.20 (-0.14%)
Price as of Oct 02, 2026 7:30 PM EDT- $14.3BMarket Cap
- 4.49%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Neurocrine Biosc (NBIX)
$142.98-$0.20 (-0.14%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
BLACKROCK FUNDING, INC. /DE | 14.70% | 14.8M | +526,674 (+3.56%) | Dec 31, 2024 |
BLACKROCK INC. | 14.11% | 14.2M | +429,738 (+3.03%) | Jun 30, 2024 |
BLACKROCK, INC. | 13.64% | 13.7M | +326,000 (+2.38%) | Jun 30, 2026 |
VANGUARD GROUP INC | 9.65% | 9.7M | -6,258 (-0.06%) | Dec 31, 2025 |
JPMORGAN CHASE & CO | 6.36% | 6.4M | +956,607 (+14.95%) | Jun 30, 2026 |
DODGE & COX | 5.55% | 5.6M | +123,670 (+2.21%) | Jun 30, 2026 |
N/A | 4.95% | 5.0M | +247,739 (+4.98%) | Jun 30, 2026 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
VANGUARD INDEX FUNDS | 7.94% | 8.0M | +55,266 (+0.69%) | Jun 30, 2026 |
COLUMBIA FUNDS SERIES TRUST | 4.97% | 5.0M | 0 (0.00%) | Jul 31, 2026 |
DODGE & COX FUNDS | 4.39% | 4.4M | 0 (0.00%) | Jun 30, 2026 |
CALAMOS CONVERTIBLE & HIGH INCOME FUND | 2.30% | 2.3M | 0 (0.00%) | Jul 31, 2026 |
CALAMOS CONVERTIBLE OPPORTUNITIES & INCOME FUND | 2.09% | 2.1M | 0 (0.00%) | Jul 31, 2026 |
Calamos Dynamic Convertible & Income Fund | 1.83% | 1.8M | 0 (0.00%) | Jul 31, 2026 |
CALAMOS STRATEGIC TOTAL RETURN FUND | 1.82% | 1.8M | 0 (0.00%) | Jul 31, 2026 |
Current Ownership Distribution
- Institutions1.8B (70.36%)
- Mutual Funds743.5M (29.09%)
- Insiders14.0M (0.55%)
- Other0 (0.00%)
Insider Transactions
- 0.55% (14.0M)Current InsiderOwnership (%, shares)
- 0Number of InsiderBuying (last 12 months)
- $0.00Amount of InsiderBuying (last 12 months)
- 5Number of InsiderSelling (last 12 months)
- $59.7MAmount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
Boyer David W. Chief Corp. Affairs Officer | Sell | Sep 14, 2026 | $130,050.56 | 826 | $157.45 | 8,722 |
ABERNETHY MATT Chief Financial Officer | Sell | Sep 14, 2026 | $363,284.81 | 2,311 | $157.20 | 42,808 |
Keswani Sanjay Chief Medical Officer | Award | Sep 11, 2026 | $0.00 | 3,914 | $0.00 | 5,393 |
Onyia Jude Chief Scientific Officer | Award | Sep 11, 2026 | $0.00 | 3,587 | $0.00 | 24,583 |
BENEVICH ERIC Chief Commercial Officer | Award | Sep 11, 2026 | $0.00 | 6,275 | $0.00 | 70,683 |
ABERNETHY MATT Chief Financial Officer | Award | Sep 11, 2026 | $0.00 | 5,020 | $0.00 | 47,828 |
GORMAN KEVIN CHARLES | Award | Sep 11, 2026 | $0.00 | 14,343 | $0.00 | 525,636 |
Boyer David W. Chief Corp. Affairs Officer | Award | Sep 11, 2026 | $0.00 | 3,587 | $0.00 | 11,484 |
Gano Kyle Chief Executive Officer | Award | Sep 11, 2026 | $0.00 | 6,275 | $0.00 | 157,266 |
ABERNETHY MATT Chief Financial Officer | In Kind | Sep 11, 2026 | $423,199.98 | 2,709 | $156.22 | 45,119 |
Keswani Sanjay Chief Medical Officer | In Kind | Sep 11, 2026 | $329,936.64 | 2,112 | $156.22 | 3,281 |
Onyia Jude Chief Scientific Officer | In Kind | Sep 11, 2026 | $302,441.92 | 1,936 | $156.22 | 22,647 |
Delaet Ingrid Chief Regulatory Officer | Award | Sep 11, 2026 | $0.00 | 4,483 | $0.00 | 20,708 |
Boyer David W. Chief Corp. Affairs Officer | In Kind | Sep 11, 2026 | $302,441.92 | 1,936 | $156.22 | 9,548 |
GORMAN KEVIN CHARLES | In Kind | Sep 11, 2026 | $1.2M | 7,839 | $156.22 | 517,797 |
Gano Kyle Chief Executive Officer | In Kind | Sep 11, 2026 | $528,960.92 | 3,386 | $156.22 | 153,880 |
BENEVICH ERIC Chief Commercial Officer | In Kind | Sep 11, 2026 | $528,960.92 | 3,386 | $156.22 | 67,297 |
Gano Kyle Chief Executive Officer | Award | Sep 11, 2026 | $0.00 | 1,842 | $0.00 | 155,722 |
Delaet Ingrid Chief Regulatory Officer | In Kind | Sep 11, 2026 | $377,896.18 | 2,419 | $156.22 | 18,289 |
Gano Kyle Chief Executive Officer | In Kind | Sep 11, 2026 | $155,282.68 | 994 | $156.22 | 154,728 |
BENEVICH ERIC Chief Commercial Officer | Exempt | Sep 09, 2026 | $0.00 | 3,194 | $0.00 | 0 |
BENEVICH ERIC Chief Commercial Officer | Exempt | Sep 09, 2026 | $138,108.56 | 3,194 | $43.24 | 66,562 |
BENEVICH ERIC Chief Commercial Officer | Sell | Sep 09, 2026 | $333,029.94 | 2,154 | $154.61 | 64,408 |
SHERWIN STEPHEN A | Gift | Sep 02, 2026 | $0.00 | 1,000 | $0.00 | 14,860 |
Onyia Jude Chief Scientific Officer | Gift | Aug 04, 2026 | $0.00 | 2,409 | $0.00 | 20,996 |
Delaet Ingrid Chief Regulatory Officer | Exempt | Jul 10, 2026 | $0.00 | 4,367 | $0.00 | 0 |
Delaet Ingrid Chief Regulatory Officer | Exempt | Jul 10, 2026 | $462,989.34 | 4,367 | $106.02 | 20,592 |
Delaet Ingrid Chief Regulatory Officer | Sell | Jul 10, 2026 | $790,514.34 | 4,367 | $181.02 | 16,225 |
Lippoldt Darin Chief Legal Officer | Exempt | Jul 09, 2026 | $0.00 | 10,000 | $0.00 | 4,965 |
Delaet Ingrid Chief Regulatory Officer | Exempt | Jul 09, 2026 | $0.00 | 8,433 | $0.00 | 7,478 |